JAMES GLORE: Open Payments
NPI 1679034144 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,969 in 73 payments from 9 companies in 2025. Trend: 2023 $1,541 · 2024 $1,882 · 2025 $2,969
Food & beverage: $2,969
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $1,133 |
| GENZYME CORPORATION | 5 | $397 |
| UCB, Inc. | 3 | $373 |
| LEO Pharma Inc. | 10 | $356 |
| E.R. Squibb & Sons, L.L.C. | 4 | $205 |
| Janssen Biotech, Inc. | 6 | $198 |
| Incyte Corporation | 5 | $159 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, Bimzelx, Sotyktu, TREMFYA, ADBRY, ANZUPGO.
Industry payments across CA — which companies pay providers there.
